Kaiser Permanente Ventures, the Oakland, Calif.-based venture capital arm of Kaiser Permanente, closed its fifth investment fund, at $141m.
Backers included financial commitments from Kaiser Permanente and a diverse group of new and returning external strategic investors including Tufts Health Plan, Henry Ford Health System, and Highmark Ventures, a subsidiary of Highmark Health.
KPV Fund V will continue KPV’s focus on supporting companies focused on health information technology, digital health, health care services, medical devices, diagnostics, and precision medicine.
The team partners with entrepreneurs to advance solutions aligned with Kaiser Permanente’s focus on quality, affordable, and accessible health care.
Led by Sam Brasch, senior managing director, KPV has invested in more than 70 companies through its venture funds since the program’s inception in 1998.
KPV’s portfolio includes iRhythm (IRTC), an ambulatory cardiac monitoring company; Health Catalyst (HCST), an industry leader in health care analytics and outcomes improvement solutions; and Omada Health, the pioneer in digital health and behavioral change.
The firm has 20 years of venture capital investing experience, with more than $500 million under management.